M
Medy Tox Inc
KOSDAQ:086900
Medy Tox Inc
KOSDAQ:086900
Price:
128 800
KRW
-0.23%
Market Closed
Market Cap:
₩940.2B
Relative Value
The Relative Value of one Medy Tox Inc stock under the Base Case scenario is hidden KRW. Compared to the current market price of 128 800 KRW, Medy Tox Inc is hidden .
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
Medy Tox Inc Relative Value
HIDDEN
Multiples Across Competitors
Competitors Multiples
Medy Tox Inc Competitors
Medy Tox Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| KR |
M
|
Medy Tox Inc
KOSDAQ:086900
|
940.2B KRW | 3.9 | 43 | 44.8 | 44.8 | |
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD | 33 690 872.8 | -160 127.7 | -194 446.1 | -192 227.3 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
407.7B USD | 6.7 | 97.4 | 16 | 22.2 | |
| US |
|
Astria Therapeutics Inc
NASDAQ:ATXS
|
326.4B USD | 462 374.5 | -2 631.9 | -2 389.6 | -2 389.6 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
208.4B USD | 5.7 | 27 | 15.4 | 15.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
185.3B USD | 6.3 | 21.8 | 13.5 | 16.7 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
125.9B USD | 10.5 | 31.9 | 24.1 | 25.2 | |
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR | 2 091 | -533.6 | -581 | -565.5 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.5B USD | 5.7 | 18.3 | 13.7 | 15.7 | |
| AU |
|
CSL Ltd
ASX:CSL
|
70.9B AUD | 3.3 | 36 | 11.8 | 14.8 | |
| NL |
|
argenx SE
XBRU:ARGX
|
40.2B EUR | 11.4 | 36.7 | 40 | 40.9 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
